Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by Polymerase Chain Reaction arrays in human prostate cancer cell lines

Simard, 2003, Prostate cancer susceptibility genes: lessons learned and challenges posed, Endocr Relat Cancer, 10, 225, 10.1677/erc.0.0100225 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Colonna, 2008, Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012, Eur J Cancer, 44, 115, 10.1016/j.ejca.2007.10.022 Hill, 2005, The frequency of cancer in France in year 2000, and trends since 1950, Bull Cancer, 92, 7 Hsing, 2000, International trends and patterns of prostate cancer incidence and mortality, Int J Cancer, 85, 60, 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B Cook, 1999, Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants, J Urol, 161, 152, 10.1016/S0022-5347(01)62086-X Shimizu, 1991, Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County, Br J Cancer, 63, 963, 10.1038/bjc.1991.210 Sim, 2005, Changing demography of prostate cancer in Asia, Eur J Cancer, 41, 834, 10.1016/j.ejca.2004.12.033 Magee, 2004, Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer, Br J Nutr, 91, 513, 10.1079/BJN20031075 Messina, 2003, Emerging evidence on the role of soy in reducing prostate cancer risk, Nutr Rev, 61, 117, 10.1301/nr.2003.apr.117-131 Messina, 2006, An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels, J AOAC Int, 89, 1121, 10.1093/jaoac/89.4.1121 Nakamura, 2000, Determination of the levels of isoflavonoids in soybeans and soy-derived foods and estimation of isoflavonoids in the Japanese daily intake, J AOAC Int, 83, 635, 10.1093/jaoac/83.3.635 Steiner, 2008, Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics, Br J Nutr, 99, ES78, 10.1017/S0007114508965788 Pollard, 2006, Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model, Comp Med, 56, 461 Wang, 2002, Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats, Cancer Lett, 186, 11, 10.1016/S0304-3835(01)00811-4 Hedlund, 2003, Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro, Prostate, 54, 68, 10.1002/pros.10137 Fang, 2005, Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy, Clin Cancer Res, 11, 7033, 10.1158/1078-0432.CCR-05-0406 Li, 2005, Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells, Cancer Res, 65, 6934, 10.1158/0008-5472.CAN-04-4604 Barnes, 1995, Biochemical targets of the isoflavone genistein in tumor cell lines, Proc Soc Exp Biol Med, 208, 103, 10.3181/00379727-208-43840 Satih, 2008, Soy phytoestrogens and breast cancer chemoprevention: molecular mechanisms, Curr Nutr Food Sci, 4, 259, 10.2174/157340108786263658 Fotsis, 1993, Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc Natl Acad Sci USA, 90, 2690, 10.1073/pnas.90.7.2690 Fotsis, 1995, Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis, J Nutr, 125, 790S Krishan, 1975, Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining, J Cell Biol, 66, 188, 10.1083/jcb.66.1.188 Favy, 2000, Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines, Biochem Biophys Res Commun, 274, 73, 10.1006/bbrc.2000.3100 Oki, 2004, Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line, FEBS Lett, 577, 55, 10.1016/j.febslet.2004.09.085 Shenouda, 2004, Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro, Nutr Cancer, 49, 200, 10.1207/s15327914nc4902_12 Kobayashi, 2002, Effect of flavonoids on cell cycle progression in prostate cancer cells, Cancer Lett, 176, 17, 10.1016/S0304-3835(01)00738-8 el-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P Gartel, 2002, The role of the cyclin-dependent kinase inhibitor p21 in apoptosis, Mol Cancer Ther, 1, 639 Handayani, 2006, Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells, J Nutr, 136, 75, 10.1093/jn/136.1.75 Karan, 2002, Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells, Carcinogenesis, 23, 967, 10.1093/carcin/23.6.967 Ko, 1997, p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner, Mol Cell Biol, 17, 7220, 10.1128/MCB.17.12.7220 Padmanabhan, 2004, DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer, J Clin Pathol, 57, 1057, 10.1136/jcp.2004.016436 Takisawa, 2000, Eukaryotic DNA replication: from pre-replication complex to initiation complex, Curr Opin Cell Biol, 12, 690, 10.1016/S0955-0674(00)00153-8 Berner, 1995, TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue, J Pathol, 176, 299, 10.1002/path.1711760312 Zheng, 2006, Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines, Hum Mutat, 27, 1062, 10.1002/humu.9457 Agarwal, 2000, Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents, Biochem Pharmacol, 60, 1051, 10.1016/S0006-2952(00)00385-3 Aragon-Ching, 2008, The role of angiogenesis inhibitors in prostate cancer, Cancer J, 14, 20, 10.1097/PPO.0b013e318161c014 Li, 2002, Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein, Cancer Lett, 186, 157, 10.1016/S0304-3835(02)00349-X Akiyama, 1987, Genistein, a specific inhibitor of tyrosine-specific protein kinases, J Biol Chem, 262, 5592, 10.1016/S0021-9258(18)45614-1 Wang, 2007, Genistein chemoprevention of prostate cancer in TRAMP mice, J Carcinog, 6, 3, 10.1186/1477-3163-6-3 Gadgeel, 2009, Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines, Cancer, 115, 2165, 10.1002/cncr.24250 Zhang, 2006, Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system, J Pathol, 208, 453, 10.1002/path.1937 Buzza, 2003, Mutations in the COL4A4 gene in thin basement membrane disease, Kidney Int, 63, 447, 10.1046/j.1523-1755.2003.00780.x Lehrer, 2004, Serum interleukin-8 is elevated in men with prostate cancer and bone metastases, Technol Cancer Res Treat, 3, 411, 10.1177/153303460400300501 Trojan, 2005, Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines, Anticancer Res, 25, 183 Engl, 2006, Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix, Life Sci, 78, 1784, 10.1016/j.lfs.2005.08.019 Lendeckel, 1999, Role of alanyl aminopeptidase in growth and function of human T cells (review), Int J Mol Med, 4, 17 Ishii, 2001, Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells, Biol Pharm Bull, 24, 226, 10.1248/bpb.24.226